Kawaguchi Tomoya 川口知哉

… Alternative Names

川口知哉カワグチトモヤ

KAWAGUCHI Tomoya 川口知哉

Less

Researcher Number	70254422
Affiliation (Current)	2023: 大阪公立大学, 大学院医学研究科, 教授
Affiliation (based on the past Project Information) *help	2018 – 2019: 大阪市立大学, 大学院医学研究科, 教授 2017: 大阪市立大学, 大学院医学研究科, 准教授 2014: 大阪市立大学, 医学部, 教授
Review Section/Research Field	Principal Investigator Tumor biology Except Principal Investigator Clinical oncology
Keywords	Principal Investigator 肺癌 / 発がん / 環境因子 / ゲノム解析 / 非小細胞肺癌 / ゲノム異常 / 肺がん / 遺伝子変異 / 発癌 Except Principal Investigator 非小細胞肺癌 … More / 癌性胸膜炎 / 分子標的治療 / 薬力学 / 薬物動態 / FDG-PET / 化学療法 / サイトケラチン Less

Mutational analysis on carcinogenesis in multiple primary lung cancersPrincipal Investigator
- Principal Investigator
  
  Kawaguchi Tomoya
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor biology
- Research Institution
  Osaka City University
Nobel pharmacodynamics evaluation of molecular targeting agents: PHarmacokinetic/PHarmacodynamic Assessment on Malignant Effusions (PHAME)
- Principal Investigator
  
  KUBO Akihito
- Project Period (FY)
  2011 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  Aichi Medical University

All 2020 2019 2018 2017 2015 2014 2013 2011 Other

All Journal Article Presentation

[Journal Article] Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i>2020
- Author(s)
  Imoto Waki、Yamada Koichi、Yamairi Kazushi、Shibata Wataru、Namikawa Hiroki、Yukawa Satomi、Yoshii Naoko、Nakaie Kiyotaka、Hirose Asao、Koh Hideo、Watanabe Tetsuya、Asai Kazuhisa、Nakamae Hirohisa、Kaneko Yukihiro、Kawaguchi Tomoya、Hino Masayuki、Kakeya Hiroshi
- Journal Title
  
  Intern. Med.
  
  Volume: 59 Issue: 2 Pages: 193-198
- DOI
  10.2169/internalmedicine.3358-19
- NAID
  130007785083
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2020-01-15
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study2020
- Author(s)
  Tamiya Akihiro、Koh Yasuhiro、Isa Shun‐ichi、Kubo Akihito、Ando Masahiko、Saka Hideo、Yoshimoto Naoki、Takeo Sadanori、Adachi Hirofumi、Tagawa Tsutomu、Kawashima Osamu、Yamashita Motohiro、Kataoka Kazuhiko、Takenoyama Mitsuhiro、Takeuchi Yukiyasu、Watanabe Katsuya、Matsumura Akihide、Kawaguchi Tomoya
- Journal Title
  
  Cancer Medicine
  
  Volume: 9 Issue: 7 Pages: 2343-2351
- DOI
  10.1002/cam4.2897
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-18K07443
[Journal Article] Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors2020
- Author(s)
  Matsumoto Yoshiya、Sawa Kenji、Fukui Mitsuru、Oyanagi Jun、Yoshimoto Naoki、Suzumura Tomohiro、Watanabe Tetsuya、Kaneda Hiroyasu、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Yamamoto Nobuyuki、Hirata Kazuto、Koh Yasuhiro、Kawaguchi Tomoya
- Journal Title
  
  Lung Cancer
  
  Volume: 139 Pages: 80-88
- DOI
  10.1016/j.lungcan.2019.10.029
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR ‐mutant non‐small cell lung cancer2019
- Author(s)
  Matsumoto Yoshiya、Sawa Kenji、Fukui Mitsuru、Oyanagi Jun、Izumi Motohiro、Ogawa Koichi、Suzumura Tomohiro、Watanabe Tetsuya、Kaneda Hiroyasu、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Yamamoto Nobuyuki、Koh Yasuhiro、Kawaguchi Tomoya
- Journal Title
  
  Cancer Science
  
  Volume: 110 Issue: 10 Pages: 3244-3254
- DOI
  10.1111/cas.14156
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Isoflavone Aglycones Attenuate Cigarette Smoke-Induced Emphysema via Suppression of Neutrophilic Inflammation in a COPD Murine Model.2019
- Author(s)
  Kojima K, Asai K, Kubo H, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
- Journal Title
  
  Nutrients
  
  Volume: 11 Issue: 9 Pages: 2023-2023
- DOI
  10.3390/nu11092023
- NAID
  120006716419
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08660, KAKENHI-PROJECT-17K07176
[Journal Article] Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.2019
- Author(s)
  Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
- Journal Title
  
  International Journal of COPD
  
  Volume: 14 Pages: 2507-2516
- DOI
  10.2147/copd.s226623
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08660, KAKENHI-PROJECT-17K07176
[Journal Article] Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).2019
- Author(s)
  Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 49 Issue: 10 Pages: 947-955
- DOI
  10.1093/jjco/hyz088
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08915, KAKENHI-PROJECT-17K07176
[Journal Article] Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity2019
- Author(s)
  Kyomoto Yohkoh、Asai Kazuhisa、Yamada Kazuhiro、Okamoto Atsuko、Watanabe Tetsuya、Hirata Kazuto、Kawaguchi Tomoya
- Journal Title
  
  Respiratory Investigation
  
  Volume: 57 Issue: 5 Pages: 499-505
- DOI
  10.1016/j.resinv.2019.03.014
- NAID
  120006890446
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Astaxanthin Suppresses Cigarette Smoke-Induced Emphysema through Nrf2 Activation in Mice.2019
- Author(s)
  Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
- Journal Title
  
  Marine Drugs
  
  Volume: 17 Issue: 12 Pages: 673-673
- DOI
  10.3390/md17120673
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08660, KAKENHI-PROJECT-17K07176
[Journal Article] Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy2019
- Author(s)
  Yamamoto Norio、Watanabe Tetsuya、Yamada Kazuhiro、Nakai Toshiyuki、Suzumura Tomohiro、Sakagami Kazuki、Yoshimoto Naoki、Sato Kanako、Tanaka Hidenori、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Kanazawa Hiroshi、Hirata Kazuto、Kawaguchi Tomoya
- Journal Title
  
  Journal of Thoracic Disease
  
  Volume: 11 Issue: 3 Pages: 936-943
- DOI
  10.21037/jtd.2019.01.88
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non?small Cell Lung Cancer2018
- Author(s)
  Yoshimura Naruo、Tada Takuhito、Matsumoto Yoshiya、Sawa Kenji、Yoshimoto Naoki、Suzumura Tomohiro、Tanaka Hidenori、Mitsuoka Shigeki、Kimura Tatsuo、Tamiya Tomohiro、Hirashima Tomonori、Kawaguchi Tomoya、Kudoh Shinzoh、Hosono Masako、Hirata Kazuto
- Journal Title
  
  American Journal of Clinical Oncology
  
  Volume: 41 Issue: 10 Pages: 967-971
- DOI
  10.1097/coc.0000000000000412
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis2018
- Author(s)
  Garassino Marina Chiara、Kawaguchi Tomoya、Gregorc Vanesa、Rulli Eliana、Ando Masahiko、Marsoni Silvia、Isa Shun-ichi、Novello Silvia、Farina Gabriella、Barni Sandro、Torri Valter、Cinquini Michela
- Journal Title
  
  ESMO Open
  
  Volume: 3 Issue: 6 Pages: e000327-e000327
- DOI
  10.1136/esmoopen-2018-000327
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-na?ve advanced non-squamous non-small cell lung cancer with EGFR mutations2018
- Author(s)
  Tamiya Motohiro、Tamiya Akihiro、Shiroyama Takayuki、Takeoka Sawa、Naito Yujiro、Omachi Naoki、Kimura Yohei、Morishita Naoko、Suzuki Hidekazu、Okamoto Norio、Okishio Kyoichi、Kawaguchi Tomoya、Atagi Shinji、Hirashima Tomonori
- Journal Title
  
  Investigational New Drugs
  
  Volume: 36 Issue: 4 Pages: 608-614
- DOI
  10.1007/s10637-017-0527-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] 肺がん薬物療法の歴史とがん免疫療法の発展2018
- Author(s)
  川口知哉、光岡茂樹、金田裕靖、鈴村倫弘、澤兼士、渡辺徹也、浅井一久
- Journal Title
  
  大阪市医学会雑誌
  
  Volume: 67 Pages: 7-14
- NAID
  120006549652
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy2017
- Author(s)
  Tambo Yuichi、Hosomi Yukio、Sakai Hiroshi、Nogami Naoyuki、Atagi Shinji、Sasaki Yasutsuna、Kato Terufumi、Takahashi Toshiaki、Seto Takashi、Maemondo Makoto、Nokihara Hiroshi、Koyama Ryo、Nakagawa Kazuhiko、Kawaguchi Tomoya、Okamura Yuta、Nakamura Osamu、Nishio Makoto、Tamura Tomohide
- Journal Title
  
  Invest New Drugs
  
  Volume: 35 Issue: 2 Pages: 217-226
- DOI
  10.1007/s10637-017-0435-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07176
[Journal Article] PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort2017
- Author(s)
  Sawa Kenji、Koh Yasuhiro、Kawaguchi Tomoya、Kambayashi Satoshi、Asai Kazuhisa、Mitsuoka Shigeki、Kimura Tatsuo、Yoshimura Naruo、Yoshimoto Naoki、Kubo Akihito、Saka Hideo、Matsumura Akihide、Wanibuchi Hideki、Yamamoto Nobuyuki、Nishiyama Noritoshi、Hirata Kazuto
- Journal Title
  
  Lung Cancer
  
  Volume: 112 Pages: 96-101
- DOI
  10.1016/j.lungcan.2017.07.039
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-17K09162, KAKENHI-PROJECT-15K06878, KAKENHI-PROJECT-15K09185, KAKENHI-PROJECT-15K09226
[Journal Article] Association between environmental tobacco smoke exposure and the occurrence of EGFR mutations and ALK-rearrangements in never-smokers with non-small cell lung cancer: analyses from a prospective multinational ETS registry.2017
- Author(s)
  Kubo A, Soo RA, Ando M, Kawaguchi T, Ahn MJ, Ou S-HI
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 18 Issue: 5 Pages: 535-42
- DOI
  10.1016/j.cllc.2017.01.005
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176
[Journal Article] Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR2017
- Author(s)
  Watanabe Masaru、Kawaguchi Tomoya、Isa Shun-ichi、Ando Masahiko、Tamiya Akihiro、Kubo Akihito、Saka Hideo、Takeo Sadanori、Adachi Hirofumi、Tagawa Tsutomu、Kawashima Osamu、Yamashita Motohiro、Kataoka Kazuhiko、Ichinose Yukito、Takeuchi Yukiyasu、Watanabe Katsuya、Matsumura Akihide、Koh Yasuhiro
- Journal Title
  
  EBioMedicine
  
  Volume: 21 Pages: 86-93
- DOI
  10.1016/j.ebiom.2017.06.003
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-15K06878
[Journal Article] Reply to G Spitzer, et al; F Zhou,et al; and B Biswas.2015
- Author(s)
  Kawaguchi T, Ando M, Kubo A.
- Journal Title
  
  J Clin Oncol
  
  Volume: 33 Issue: 5 Pages: 526-7
- DOI
  10.1200/jco.2014.58.5315
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314
[Journal Article] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.2015
- Author(s)
  Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
- Journal Title
  
  The Oncologist
  
  Volume: 20 Issue: 3 Pages: 1-9
- DOI
  10.1634/theoncologist.2014-0285
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-25460896
[Journal Article] Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small-cell lung cancer patients with an EGFR-activating mutation using picodroplet digital PCR.2015
- Author(s)
  Watanabe M, Kawaguchi T, Isa S-I, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y.
- Journal Title
  
  Clin Cancer Res
  
  Volume: in press Issue: 15 Pages: 3552-3560
- DOI
  10.1158/1078-0432.ccr-14-2151
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
[Journal Article] Long-term Complete Response in a Patient with Disseminated Pulmonary Pleomorphic Carcinoma Induced by Cisplatin and Gemcitabine2014
- Author(s)
  Tamiya A, Asami K, Shimizu S, Matusmura A, Isa S-I, Okishio K, Kitaichi M, Atagi S, Takada M, Kawaguchi T, Kubo A.
- Journal Title
  
  Intern. Med.
  
  Volume: 53 Issue: 22 Pages: 2625-2628
- DOI
  10.2169/internalmedicine.53.2637
- NAID
  130004713245
- ISSN
  0918-2918, 1349-7235
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23501314
[Journal Article] Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2014
- Author(s)
  Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A.
- Journal Title
  
  J Clin Oncol
  
  Volume: 32 Issue: 18 Pages: 1902-8
- DOI
  10.1200/jco.2013.52.4694
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
[Journal Article] Long-term complete response in a patient with disseminated pulmonary pleomorphic carcinoma induced by cisplatin and gemcitabine.2014
- Author(s)
  Tamiya A, Asami K, Shimizu S, Matusmura A, Isa S-I, Okishio K, Kitaichi M, Atagi S, Takada M, Kawaguchi T, Kubo A
- Journal Title
  
  Internal Medicine (in press)
  
  Volume: na
- NAID
  130004713245
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314
[Journal Article] Role of consolidation chemotherapy after concurrent chemo-radiotherapy in locally advanced non-small-cell lung cancer.2014
- Author(s)
  Tsujino K, Kurata T, Kawaguchi T, Kubo A, Takada M, Ando M.
- Journal Title
  
  J Thorac Oncol
  
  Volume: 9 Issue: 1 Pages: e7-e8
- DOI
  10.1097/jto.0000000000000035
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
[Journal Article] Human papilloma virus in non-small cell lung cancer in never smokers: A systematic review of the literature.2014
- Author(s)
  Hasegawa Y, Ando M, Kubo A, Isa SI, Yamamoto S, Tsujino K, Kurata T, Ou SH, Takada M, Kawaguchi T
- Journal Title
  
  Lung Cancer
  
  Volume: 8 Issue: 1 Pages: 8-13
- DOI
  10.1016/j.lungcan.2013.10.002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
[Journal Article] Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2014
- Author(s)
  Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A
- Journal Title
  
  J Clin Oncol (in press)
  
  Volume: na
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314
[Journal Article] Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study2013
- Author(s)
  Kawaguchi T, Ando M, Ito N, Isa SI, Tamiya A, Shimizu S, Saka H, Kubo A, Koh Y, Matsumura A
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 14 Issue: 5 Pages: 596-600
- DOI
  10.1016/j.cllc.2013.03.001
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-24501363, KAKENHI-PROJECT-25460896
[Journal Article] Rationale and design of JME study: Japan Molecular Epidemiology for lung cancer study.2013
- Author(s)
  Kawaguchi T
- Journal Title
  
  Clin Lung Cancer (in press)
  
  Volume: 未定
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314
[Journal Article] Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non-Small-Cell Lung Cancer?: A Pooled Analysis of the Literature.2013
- Author(s)
  Tsujino K, Kurata T, Yamamoto S, Kawaguchi T, Kubo A, Isa S, Hasegawa Y, Ou SH, Takada M, Ando M
- Journal Title
  
  J Thorac Oncol
  
  Volume: 8 Issue: 9 Pages: 1181-9
- DOI
  10.1097/jto.0b013e3182988348
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
[Presentation] Association between low-frequency pretreatment EGFR T790M mutation and tumor immune microenvironment in patients with EGFR-mutated non-small cell lung cancer.2019
- Author(s)
  Yoshiya Matsumoto, Tomoya Kawaguchi, Yasuhiro Koh, Motohiro Izumi
- Organizer
  American Association for Cancer Research Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Presentation] Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors2018
- Author(s)
  Yoshiya Matsumoto, Kenji Sawa, Jun Oyanagi, Mitsuru Fukui, Naoki Yoshimoto, Tomohiro Suzumura, Shigeki Mitsuoka, Kazuhisa Asai, Tatsuo Kimura, Nobuyuki Yamamoto, Tomoya Kawaguchi, Kazuto Hirata, and Yasuhiro Koh
- Organizer
  American Association of Cancer Research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Presentation] Japan Molecular Epidemiology for lung cancer (JME) study and beyond2018
- Author(s)
  Tomoya Kawaguchi
- Organizer
  The 1st Guangdong Association of Thoracic Disease Symposium for Multidisciplinary Therapy of Lung Cancer
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Presentation] Impact of de Novo T790M on Outcome for Resected NSCLC from EGFR Mutant Cohort of Japan Molecular Epidemiology (JME) Study2018
- Author(s)
  Y. Matsumoto, T. Kawaguchi, K. Sawa, S. Isa, M. Ando, A. Tamiya, A. Kubo, H. Saka, A. Matsumura, Y. Koh
- Organizer
  World Congress of Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Presentation] molecular epidemiology2017
- Author(s)
  Kawaguchi t
- Organizer
  世界肺癌学会総会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07176
[Presentation] Impacts of environmental tobacco smoke on EGFR mutations and ALK rearrangements in never smokers with non-small cell lung cancer: Analyses on a prospective multinational ETS registry.2013
- Author(s)
  Kubo A, Ando M, Soo RA, Kawaguchi T, Ou S-HI, Ahn M-J.
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney, Australia
- Data Source
  KAKENHI-PROJECT-23501314
[Presentation] Impact of environmental tobacco smoke (ETS) on ALK rearrangements in never smokers (NS) with non-small cell lung cancer (NSCLC): Analyses on a prospective multinational ETS registry.2013
- Author(s)
  Kubo A, Ando M, Soo RA, Kawaguchi T, Ou S-HI, Ahn M-J.
- Organizer
  Annual Meeting of the American Society of Clinical Oncology
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23501314
[Presentation] Randomized phase III trial of erlotinib (E) versus (v) docetaxel (D) as second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC) who have wild type or mutant epidermal growth factor receptor (EGFR): Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2013
- Author(s)
  Okano Y, Ando M, Asami K, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A, Kawaguchi T.
- Organizer
  Annual Meeting of the American Society of Clinical Oncology
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23501314
[Presentation] 非小細胞肺癌(NSCLC)の癌性胸膜炎(MPE)におけるゲフィチニブの薬力学・薬物動態・臨床第II相試験2011
- Author(s)
  久保昭仁、洪　泰浩、堀　隆、伊佐俊一、福岡順也、川口知哉、安藤昌彦、岡本　勇、北市正則、安宅信二、河原正明、楠　洋子、山口悦郎、中川和彦、高田　實
- Organizer
  第51回日本呼吸器学会学術講演会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-23501314
[Presentation] Updated overall survival (OS) results of randomized phase III trial of erlotinib (E) versus (v) docetaxel (D) as second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC): Docetaxel and Erlotinib Lung cancer TriAl (DELTA).
- Author(s)
  Ibata H, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A, Kawaguchi T.
- Organizer
  Annual Meeting of the American Society of Clinical Oncology
- Place of Presentation
  Chicago, IL, USA.
- Year and Date
  2014-05-30 – 2014-06-03
- Data Source
  KAKENHI-PROJECT-23501314
[Presentation] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.
- Author(s)
  Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Kurata T, Ou SH.
- Organizer
  Annual Meeting of the American Society of Clinical Oncology
- Place of Presentation
  Chicago, IL, USA.
- Year and Date
  2014-05-30 – 2014-06-03
- Data Source
  KAKENHI-PROJECT-23501314

1. KOU Yasuhiro (80426519)

# of Collaborated Projects: 2 results

# of Collaborated Products: 12 results
2. KUBO Akihito (60416245)

# of Collaborated Projects: 1 results

# of Collaborated Products: 20 results
3. FUKUOKA Junya (00324575)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. TAKADA Minoru (20373516)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
5. ISA Shun-Ichi (60421913)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
6. ASAI Kazuhisa

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
7. KIMURA Tatsuo

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kawaguchi Tomoya 川口 知哉

川口 知哉 カワグチ トモヤ

KAWAGUCHI Tomoya 川口 知哉

Research Projects

Research Products

Co-Researchers

Mutational analysis on carcinogenesis in multiple primary lung cancersPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Nobel pharmacodynamics evaluation of molecular targeting agents: PHarmacokinetic/PHarmacodynamic Assessment on Malignant Effusions (PHAME)

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i>2020

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR ‐mutant non‐small cell lung cancer2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Isoflavone Aglycones Attenuate Cigarette Smoke-Induced Emphysema via Suppression of Neutrophilic Inflammation in a COPD Murine Model.2019

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity2019

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Astaxanthin Suppresses Cigarette Smoke-Induced Emphysema through Nrf2 Activation in Mice.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non?small Cell Lung Cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis2018

Kawaguchi Tomoya 川口知哉

川口知哉カワグチトモヤ

KAWAGUCHI Tomoya 川口知哉